Statistics for Madrigal Pharmaceuticals (id:7330 MDGL)

Valuation metrics

Market cap

7.39B

Enterprise value

6.53B

Trailing P/E (ttm)

-17.39

Forward P/E

-24.29

PEG ratio

-24.29

Price/Sales (ttm)

96.27

Price/Book (mrq)

9.51

Enterprise Value/Revenue

84.99

Enterprise Value/EBITDA

-11.93

Overview

Shares outstanding

21.81M

Float

10.73M

Shares short

4.05M

% Held by insiders

0.15%

% Held by institutions

1.04%

Average volume (10 days)

896.43K

Average volume (90 days)

Price summary

52-Week low

168.25

52-Week high

368.29

52-Week change

43.21%

Beta

-0.47

50-Day moving average

238.36

200-Day moving average

244.46

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

July 25th, 2016

Ex-dividend date

Last split factor

2:1

Last split date

July 25th, 2016

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-187.06%

Operational effectiveness

Return on assets

-52.25%

Return on equity

-129.76%

Income statement

Revenue (ttm)

3.70

Revenue per share (ttm)

3.70

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-547,180,032.00

Net income to common (ttm)

-518,670,016.00

Diluted EPS (ttm)

-25.03

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

998.63M

Total cash per share (mrq)

45.79

Total debt (mrq)

119.14M

Total Debt/Equity (mrq)

15.33

Current ratio (mrq)

598.10%

Book value per share (mrq)

35.64

Cash flow

Cash flow statement

-431,019,008.00

Levered free cash flow (LFCF)

-263,114,752.00